.png){kind=logo}
AI-based Development
AI-based development
Molecular mechanisms
Discovering the hidden molecular cargo and selective therapeutic effects of stem cells and secreted extracellular vesicle (EV) subpopulations
Therapeutic EVs
Demonstrating the superior combined anti-tumor activity of specific EV subpopulations and their targeted drug delivery abilities using human tumor models
Validation and applicability
Translating animal model results to humans – increasing prediction validity and applicability for clinical trials
AI-based scale-up
Precise scale-up production via real-time EV monitoring and
AI analysis
Competitive Advantages
Technological Platform
EV libraries combined with AI for precise production, therapeutics, and drug delivery – a novel platform of cancer therapy
First product to market
PL-Ex1, EV-based treatment for refractory NSCLC
Long-Term Roadmap
Market driven by increasing prevalence of solid cancers
.png)
Extensive IP
Patents granted
and pending following extensive research
Experienced Team
Translational Science, Molecular biology, and data science
Growing Market
Global cancer therapy Market to reach $209.2 billion by 2026
.png){kind=logo}